1257007
Ethambutol hydrochloride
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 1070-11-7
Synonym(S): Ethambutol dihydrochloride, 2,2′-(1,2-Ethanediyldiimino)bis-1-butanol dihydrochloride, Emb
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 200 MG | 1257007-200-MG | In Stock | ₹ 40,756.13 |
1257007 - 200 MG
In Stock
Quantity
1
Base Price: ₹ 40,756.13
GST (18%): ₹ 7,336.103
Total Price: ₹ 48,092.233
grade
pharmaceutical primary standard
API family
ethambutol
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
CC[C@@H](CO)NCCN[C@H](CO)CC.Cl.Cl
InChI
1S/C10H24N2O2.2ClH/c1-3-9(7-13)11-5-6-12-10(4-2)8-14;;/h9-14H,3-8H2,1-2H3;2*1H/t9-,10-;;/m0../s1
InChI key
AUAHHJJRFHRVPV-BZDVOYDHSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Ethambutol hydrochloride Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 24,742.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Ethambutol hydrochloride European Pharmacopoeia (EP) Reference Standard | 1070-11-7 | MFCD21364080 | | -- | ₹ 17,007.90 | ||
Sigma Aldrich Fine Chemicals Biosciences Ethambutol dihydrochloride antimycobacterial | 1070-11-7 | MFCD21364080 | 100G | -- | ₹ 67,002.76 | ||
Sigma Aldrich Fine Chemicals Biosciences Ethambutol dihydrochloride antimycobacterial | 1070-11-7 | MFCD21364080 | 25G | -- | ₹ 20,932.80 | ||
Ethambutol hydrochloride | -- | ₹ 23,815.00 | ||
Ethambutol hydrochloride | -- | ₹ 14,267.35 | ||
Ethambutol for system suitability | -- | ₹ 14,267.35 | ||
Ethambutol dihydrochloride | -- | ₹ 22,010.00 - ₹ 37,510.00 | ||
Ethambutol dihydrochloride | -- | ₹ 22,010.00 - ₹ 37,510.00 | ||
Ethambutol (dihydrochloride) | -- | ₹ 7,832.00 - ₹ 23,318.00 |
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Ethambutol is an antimycobacterial used to treat tuberculosis in combination with other antibiotics to reduce the development of drug resistance. It has been used to study multidrug-resistant tuberculosis (MDR-TB) in highest-incidence-rate areas in China.
- Biochem/physiol Actions: Ethambutol is bacteriostatic against actively growing TB bacilli. Mycolic acids attach to the 5′-hydroxyl groups of D-arabinose residues of arabinogalactan and form mycolyl-arabinogalactan-peptidoglycan complex in the cell wall. Ethambutol disrupts arabinogalactan synthesis by inhibiting arabinosyltransferases, specifically those in Mycobacterium, interfering with the biosynthesis of arabinogalactans found in the cell wall of mycobacteria and leading to increased cell wall permeability.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable